Hematopoietic stem-cell gene therapy is associated with restored white matter microvascular function in cerebral adrenoleukodystrophy.
Hematopoietic stem-cell gene therapy is associated with restored white matter microvascular function in cerebral adrenoleukodystrophy.
复制标题
DOI:
10.1038/s41467-023-37262-w
复制
发表时间:
2023-04-05
影响因子:
16.6
通讯作者:
Musolino, Patricia L.
中科院分区:
文献类型:
--
作者:
Lauer, Arne;Speroni, Samantha L.;Choi, Myoung;Da, Xiao;Duncan, Christine;McCarthy, Siobhan;Krishnan, Vijai;Lusk, Cole A.;Rohde, David;Hansen, Mikkel Bo;Kalpathy-Cramer, Jayashree;Loes, Daniel J.;Caruso, Paul A.;Williams, David A.;Mouridsen, Kim;Emblem, Kyrre E.;Eichler, Florian S.;Musolino, Patricia L.
Blood-brain barrier disruption marks the onset of cerebral adrenoleukodystrophy (CALD), a devastating cerebral demyelinating disease caused by loss of ABCD1 gene function. The underlying mechanism are not well understood, but evidence suggests that microvascular dysfunction is involved. We analyzed cerebral perfusion imaging in boys with CALD treated with autologous hematopoietic stem-cells transduced with the Lenti-D lentiviral vector that contains ABCD1 cDNA as part of a single group, open-label phase 2-3 safety and efficacy study (NCT01896102) and patients treated with allogeneic hematopoietic stem cell transplantation. We found widespread and sustained normalization of white matter permeability and microvascular flow. We demonstrate that ABCD1 functional bone marrow-derived cells can engraft in the cerebral vascular and perivascular space. Inverse correlation between gene dosage and lesion growth suggests that corrected cells contribute long-term to remodeling of brain microvascular function. Further studies are needed to explore the longevity of these effects. Cerebral adrenoleukodystrophy (CALD) is a demyelinating disease caused by loss of ABCD1 gene function. Here the authors investigate white matter structural and microvascular changes in boys with CALD that received gene therapy with autologous hematopoietic stem-cells.
登录
查看更多内容
DOI:
10.1073/pnas.1205858109
发表时间:
2012-09-11
影响因子:
11.1
作者:
Capotondo, Alessia;Milazzo, Rita;Biffi, Alessandra
通讯作者:
Biffi, Alessandra
DOI:
10.1056/nejmoa1700554
发表时间:
2017-10-26
期刊:
The New England journal of medicine
影响因子:
--
作者:
Eichler F;Duncan C;Musolino PL;Orchard PJ;De Oliveira S;Thrasher AJ;Armant M;Dansereau C;Lund TC;Miller WP;Raymond GV;Sankar R;Shah AJ;Sevin C;Gaspar HB;Gissen P;Amartino H;Bratkovic D;Smith NJC;Paker AM;Shamir E;O'Meara T;Davidson D;Aubourg P;Williams DA
通讯作者:
Williams DA
影响因子:
3.9
作者:
Kemp, S;Pujol, A;Hugo, HW
通讯作者:
Hugo, HW
DOI:
10.1038/jcbfm.2011.153
发表时间:
2012-02
期刊:
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
影响因子:
--
作者:
Jespersen SN;Østergaard L
通讯作者:
Østergaard L
影响因子:
9.9
作者:
Chen, Y. W.;Gurol, M. E.;Smith, E. E.
通讯作者:
Smith, E. E.